Australia has provisionally approved the use of the AstraZeneca vaccine against Covid-19 as a booster shot for people aged 18 years and older.
However, in...
Doubts cast by several scientists and politicians alike over the efficacy of the AstraZeneca Covid vaccine, developed in collaboration with the Oxford University "probably...
AstraZeneca's Vaxzevria significantly boosted levels of antibodies against the Omicron SARS-CoV-2 variant following a third dose booster, according to data from a new...
A third dose of AstraZeneca's Covid vaccine, named Covishield in India, produces similar neutralising antibody levels against Omicron as after two doses against the...
AstraZeneca's long-acting antibody combination is both able to prevent and treat Covid-19, according to the phase three results released on Monday.
The drug, AZD7442, is...
UK drugmaker AstraZeneca has partnered with scientists at Imperial College London to develop a new vaccine technology to treat cancer, heart conditions and other...
The incidence of rare blood clot is higher following a Covid-19 infection than two doses of AstraZeneca or Pfizer/BioNTech vaccines, according to a new...
AstraZeneca India on Wednesday signed an MoU with Bengaluru-based Docon Technologies for digitizing 1,000 clinics across India.
Under the partnership, Don will equip the identified...
British-Swedish biopharmaceutical firm AstraZeneca has in partnership with the University of Oxford rolled out human trials for booster shots against the Beta Covid variant.
The...